日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants

基于结构的共价SARS-CoV-2主蛋白酶抑制剂设计,靶向耐尼马替利韦的E166突变体

Cai, Zhengjun; Kohaal, Navita; Georgiou, Kyriakos; Liang, Xueying; Chi, Xiang; Tan, Haozhou; Tan, Bin; Li, Kan; Fan, Guangjin; Lambrinidis, George; Kolocouris, Antonios; Deng, Xufang; Chen, Yu; Wang, Jun

Dysregulation of microRNAs and Centromere Protein Genes in Prostate Cancer and Metastatic Progression

前列腺癌中microRNA和着丝粒蛋白基因的失调及其在转移进展中的作用

Comuzzi, Barbara; Lambrinidis, Leonidas; Rogatsch, Hermann; Godoy-Tundidor, Sonia; Knezevic, Nikola; Krhen, Ivan; Marekovic, Zvonimir; Bartsch, Georg; Klocker, Helmut; Hobisch, Alfred; Culig, Zoran; Somuncu, Makbule Nihan; Karalezli, İlknur; Göger, Yunus Emre; Zamani, Ayşe Gül; Yıldırım, Mahmut Selman; Deveci, Asuman; Avunduk, Mustafa Cihat; Karalezli, Giray

Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation"

双重COX/LOX抑制剂设计的最新进展(2020-2024):确立“炎症的四法则”

Chatzipieris, Filippos Panteleimon; Petsas, Errikos; Lambrinidis, George; Vassiliou, Stamatia; Chasapis, Christos T

Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease.

SARS-CoV-2木瓜蛋白酶样蛋白酶天然耐药突变的鉴定

Tan Haozhou, Zhang Qianru, Georgiou Kyriakos, Zhang Siyu, Li Kan, Lambrinidis George, Kolocouris Antonios, Deng Xufang, Wang Jun

A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis.

合理设计的 2C 抑制剂可防止感染肠道病毒 D68 的小鼠出现瘫痪

Li Kan, Rudy Michael J, Hu Yanmei, Tan Haozhou, Lambrinidis George, Wu Xiangmeng, Georgiou Kyriakos, Tan Bin, Frost Joshua, Wilson Courtney, Clarke Penny, Kolocouris Antonios, Zhang Qing-Yu, Tyler Kenneth L, Wang Jun

Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024)

血管紧张素II 1型受体的结构和计算见解:拮抗剂设计进展及其对高血压治疗的意义(2020-2024)

Chatzipieris, Filippos Panteleimon; Petsas, Errikos; Lambrinidis, George; Matsoukas, John M; Mavromoustakos, Thomas

Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor

杂环羰基氧甲酰亚胺作为人类腺苷 A3 受体选择性拮抗剂的命中到先导化合物优化

Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, Maria Georgiou, Athanasios Pousias, Amy Davies, Abigail Pearce, Matthew Harris, George Lambrinidis, Panagiotis Marakos, Nicole Pouli, Antonios Kolocouris, Nikolaos Lougiakis, Graham Ladds

Towards New Scaffolds for Antimicrobial Activity-In Silico/In Vitro Workflow Introducing New Lead Compounds

构建新型抗菌活性骨架——计算机模拟/体外实验流程引入新型先导化合物

Mangana, Maria; Lambrinidis, George; Kostakis, Ioannis K; Kalpaktsi, Ioanna; Sagnou, Marina; Nicolaou, Chrysoula; Mikros, Emmanuel; Chatzipanagiotou, Stylianos; Ioannidis, Anastasios

Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer

靶向前列腺癌的双特异性PSMA-617/RM2异二聚体的合成及临床前评价

Liolios, Christos; Bouziotis, Danai; Sihver, Wiebke; Schäfer, Martin; Lambrinidis, George; Salvanou, Evangelia-Alexandra; Bauder-Wüst, Ulrike; Benesova, Martina; Kopka, Klaus; Kolocouris, Antonios; Bouziotis, Penelope

Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives

白藜芦醇甲氧基衍生物的合成及生物学评价

Fragopoulou, Elizabeth; Gkotsi, Katerina; Petsini, Filio; Gioti, Katerina; Kalampaliki, Amalia D; Lambrinidis, George; Kostakis, Ioannis K; Tenta, Roxane